Innovations in future directions & emerging therapies in diabetes and endocrinology are revolutionizing the landscape of metabolic disease treatment. Research on pancreatic beta-cell regeneration, stem cell therapy, and gene editing holds potential for long-term diabetes remission. Immunomodulatory approaches aim to halt autoimmune destruction in type 1 diabetes, while artificial intelligence-driven precision medicine is refining treatment plans for type 2 diabetes. Advancements in hormonal therapies, including novel incretin-based drugs and dual-hormone insulin delivery systems, are improving glycemic control. The integration of digital health solutions, closed-loop insulin delivery, and non-invasive glucose monitoring is enhancing patient autonomy. With continuous exploration of new targets, the future of diabetes and endocrinology promises transformative solutions for personalized and preventive care.
Mahir Khalil Ibrahim Jallo
Gulf Medical University, Canada
Yong Xiao Wang
Albany Medical College, United States
F Buck Willis
University of Belize, Belize
Sujith Rajan
NYU Long Island School of Medicine, United States
Amy Gutman
AdventHealth; Tough Love MD, United States
Paraskevi Theofilou
Hellenic Open University, Greece
Teji S Dhami
Boost your Health and Wellness, United StatesSubmit your abstract Today
Title : Adipose MTP deficiency protects against hepatic steatosis by upregulating PPAR activity
Sujith Rajan, NYU Long Island School of Medicine, United States
Title : Important roles and mechanisms of novel calcium signaling in diabetes-induced vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : Does winter melon (Benincasa hispida) improves nutritional values and ameliorating glycaemic parameters ?
Wan Rosli Wan Ishak, Universiti Sains Malaysia, Malaysia
Title : The menopausal mind: Reframing female senescence as a neuroendocrine disorder with root cause management strategies
Amy Gutman, AdventHealth; Tough Love MD, United States
Title : Diabetes reduction (pre-diabetes and type 2) with integrative medicine
F Buck Willis, University of Belize, Belize
Title : Serum fructosamine: A more accurate screening test than 3-hour OGTT for diagnosis of gestational diabetes
Sarah Exley, Broadlawns Medical Center, United States